Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in France / NCT07895758
Starting soon Observational

Assessment of the Seasonality of Depressive Symptoms in Adolescents

NCT07895758 · tracked via the Priya Life Science France tracker
Sponsor
University Hospital, Rouen
Phase
Observational
Started
2026-12-01
Last updated
2026-10-26

Condition(s) studied

Depressive Symptoms

Investigational drug(s) / intervention(s)

Measuring the intensity of the seasonality of depressive symptoms in adolescents

Measuring the intensity of the seasonality of depressive symptoms in adolescents: Adolescents who agree to participate will be invited to complete the SPAQ questionnaire either independently or with the assistance of a team member. It will be administered on a single occasion and is expected to take approximately 10 to 15 minutes to complete.

Study summary

The seasonality of affective disorders-particularly depressive symptoms-is well-documented in adults, yet it remains under-researched in adolescents. Recent studies, however, suggest that young people aged 11 to 20 experience marked seasonal fluctuations in mood. In both hospital pediatric settings and the ECLIPSE program, many adolescents are admitted due to depressive symptoms or suicidal crises; however, the role of seasonality in these cases remains largely unexplored. ECLIPSE (a Child and Adolescent Psychiatry Liaison and Emergency Consultation Team) is a service at the Rouen University Hospital dedicated to providing emergency and post-emergency care for children and adolescents experiencing psychological distress. It is designed for minors aged 3 to 16 whose psychological state requires prompt intervention, but not hospitalization. Clinical observation suggests that, for some patients, depressive manifestations follow an annual cycle. Identifying such seasonal patterns could help improve our understanding of vulnerability factors and enable the adaptation of prevention and care strategies. The Seasonal Pattern Assessment Questionnaire (SPAQ) (Reynaud et al., 2022)-used in adults (\>18 years old) to screen for seasonal affective disorder via a Global Seasonality Score (GSS)-is a simple, self-administered tool that can easily be used with adolescents. Its application in this context would allow for the assessment of the seasonality of depressive symptoms within this hospitalized population.

Eligibility

Sex
ALL
Min age
11 Years
Max age
17 Years
Healthy volunteers
No
Inclusion Criteria: * Age 11-17 years. * Hospitalization in a pediatric ward (or post-emergency pediatric psychiatric care within the ECLIPSE unit) for depressive symptoms/suicidal crisis linked to a depressive state (DSM-5 criteria). * Proficiency in French and the ability to self-complete the SPAQ questionnaire following clinical stabilization. * Provision of information to the minor and no objection from those holding parental authority (in accordance with local procedures). * First inclusion only (in the event of readmission, the initial episode is the one considered). Exclusion Criteria: * Conditions that interfere with the completion of a reliable self-report questionnaire: moderate-to-severe intellectual disability, autism spectrum disorder (ASD) with significant communication impairments, an acute mental state (severe psychotic disorganization, acute intoxication/withdrawal, delirium), or severe physical pain. * Absence of a current depressive state. * Manic/hypomanic episode predominant at the time of data collection (depressive symptoms take priority for the purpose of assessing seasonality). * Insufficient command of the French language or sensory impairments that prevent the assessment from being administered, even with assistance. * SPAQ not completed (or major missing data, rendering the GSS uninterpretable). * Patient refusal.

Primary outcome measure(s)

  • To assess the intensity of the seasonality of depressive symptoms in adolescents receiving care for child psychiatric reasons at the Rouen University Hospital — 1 day
    The intensity of the seasonality of depressive symptoms will be measured using the continuous Global Seasonality Score (GSS) from the SPAQ. The GSS is the sum of six items related to seasonal variation (sleep, social activity, mood, weight, appetite, and energy), each rated from 0 to 4, resulting in a total score ranging from 0 to 24. A high score indicates greater reported seasonal variations

Trial sites (1)

FacilityCityRegionStatus
University Rouen Hospital Rouen France

More University Hospital, Rouen trials in France

Evaluation of the Access to Healthcare Service Starting soon
Pharmacokinetic Study of the Use of Nefopam 30 mg Tablets in Patients Suffering From Acute Pain in Rheumatology Starting soon
Non-invasive Ventilation and High-speed Oxygen Therapy Effects on Heart Function - HiFlow-Heart Study Recruiting
Benefits of Early Proprioceptive Re-education Without Visual Information After Total Knee Arthroplasty Starting soon
In Utero Alcoholic Exposure: PlGF, Biomarker of Fetal Brain Lesions Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07895758 on ClinicalTrials.gov ↗ ← All trials in France